Hexagon Nutrition Board Meeting Date
Hexagon Nutrition Ltd has scheduled a Board Meeting for September 30, 2026, to discuss requisition letters for appointing directors and approving remuneration.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Hexagon Nutrition Ltd has scheduled a Board Meeting for September 30, 2026, to discuss requisition letters for appointing directors and approving remuneration.
Hexagon Nutrition Limited announced the appointment of an Executive Director, re-appointment of a Joint Managing Director, and the appointment of a Secretarial Auditor.
Hexagon Nutrition informed exchanges that its promoters abstained from voting on certain resolutions. The company is currently seeking independent legal advice regarding this matter.
Hexagon Nutrition Limited held its 33rd Annual General Meeting on September 22, 2026. The meeting transacted business as listed in the AGM notice.
Promoters and promoter group members of Hexagon Nutrition Ltd purchased 40,000 equity shares via open market transactions, with a total consideration of ₹0.26 Crore.
Dr. Nikhil Kelkar, promoter and joint MD of Hexagon Nutrition, acquired 10,000 equity shares in the open market. His stake rose from 17.27% to 17.28%.
Hexagon Nutrition delivered strong Q1 FY27 results with 43.2% revenue growth and 25.1% PAT growth. Management focused on expanding the branded portfolio and optimizing capacity utilization.
Hexagon Nutrition reported Q1 FY27 revenue of ₹1,043 Mn with 11.3% EBITDA margin. The firm focuses on specialized clinical and wellness nutrition brands like Pentasure and Pediagold.
Hexagon Nutrition Ltd reported revenue from operations of ₹104.3 Cr (+43.1% YoY) and net profit of ₹8.1 Cr (+24.6% YoY) for Q1 FY27.
Hexagon Nutrition reported strong FY26 performance with 17.8% revenue growth to ₹382.63 Cr and PAT surge of 56.1%. Focus remains on high-margin branded products and export expansion.
Hexagon Nutrition reported FY26 revenue of ₹3,826 Mn with 13.82% EBITDA margin. The company is transitioning to a listed B2C-focused player following its June 2026 IPO.
Hexagon Nutrition Ltd reported revenue from operations of ₹115 Cr (+8.0% YoY) and net profit of ₹10.9 Cr (+39.7% YoY) for Q4 FY26.